IMCD falls on 'weak' Q2 results

IMCD

30/07/2025 08:43

** Shares in IMCD IMCD.AS are down around 11% to their lowest since November 2020 after the Dutch speciality chemicals maker reported Q2 adj. EBITA miss and a slower organic growth

** "Market was concerned about a weak 2Q print from IMCD and this is what we got," says J.P.Morgan

** The brokerage flags adj. EBITA is down 6% YoY organic vs. its expectations of 2% growth, with the absolute adj. EBITA 7% below consensus

** Jefferies also points to slowing organic growth -  the consensus miss is mainly explained by weaker organic growth of  0.7%, which slowed from 4.2% in Q1

     ** "The print today might not help the narrative around the ability of the company to show organic earnings growth through-the-cycle" - JPM

** Up to the previous session's close, shares were down 22.2%​ YTD

 (Reporting by Marianna Ciabach-Malinowska)

 ((marianna.ciabach@tr.com))